San Diego-based Viking Therapeutics marked itself as a serious competitor during the weight loss drug sector in February right after revealing promising knowledge from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when specified for a weekly injection As well as in March the c